Sumatriptan

Sumatriptan is a selective serotonin (5-HT1B/1D) receptor agonist used for the acute treatment of migraine with or without aura and cluster headaches. Mediocon Inc supplies pharmaceutical-grade Sumatriptan conforming to IP / BP / EP / USP specifications.

Sumatriptan acts on 5-HT1B receptors in blood vessels, causing vasoconstriction of cranial vessels, and on 5-HT1D receptors on trigeminal nerve endings, inhibiting the release of inflammatory neuropeptides associated with migraine.

Key Features

• High-purity pharmaceutical grade API
• IP / BP / EP / USP compliant
• Full CoA and MSDS documentation
• GMP certified manufacturing facility

Applications

• Antimigraine tablet and injection formulations
• Cluster headache treatment
• Nasal spray and autoinjector manufacturing
• Serotonin agonist drug development

Why Choose Mediocon

• ISO 9001:2015 & GMP certified manufacturing
• Consistent batch-to-batch quality with full CoA
• Export-ready documentation: COO, MSDS, DMF
• Flexible MOQ for both R&D and commercial scale
• Dedicated QA support for regulatory filings

Parameter	Specification
Assay	NLT 98.0%
Loss on Drying	NMT 0.5%
Heavy Metals	NMT 20 ppm
Residue on Ignition	NMT 0.1%
Microbial Limits	Complies with pharmacopoeia
Identification	IR, HPLC Compliant
Mfg Date	MAR 2025
Exp Date	FEB 2031
Packing	25 kg HDPE drums / as per requirement